Both CD9 and CD63 are important regulators of melanoma progression and metastasis (Fan et al., 2010; Kondoh et al., 1993; Si & Hersey, 1993), and EVs have been reported to play a fundamental role in tumour metastatic niche formation (Peinado et al., 2012). The gene discussed is CD9; the disease is neoplasm.